{"id":1608,"date":"2020-02-24T23:36:39","date_gmt":"2020-02-24T23:36:39","guid":{"rendered":"http:\/\/www.trendsandtargets.com\/?p=1608"},"modified":"2020-02-25T14:01:28","modified_gmt":"2020-02-25T14:01:28","slug":"faron-pharma-lsefarn-25-02-2020","status":"publish","type":"post","link":"http:\/\/www.trendsandtargets.com\/index.php\/2020\/02\/24\/faron-pharma-lsefarn-25-02-2020\/","title":{"rendered":"Faron Pharma (LSE:FARN) 25\/02\/2020"},"content":{"rendered":"\n

#Gold #SP500 <\/strong>As we snuffle through the cold & flu season, it was interesting to note those shares which proved resilient, despite market wide hysteria apparently prompted by Coronavirus. We covered #Faron last November (link<\/a><\/strong>) and their share price has managed the opposite of catching a cold. Equally fascinating, reading “the common cold” is just one of the grouping covered by the word coronavirus, a respiratory term!<\/p>\n\n\n\n

Of course, this means the current \noutbreak of sniffles in our part of Scotland is now described by schoolchildren \nas “coronavirus”, wanting face masks and preferably some time off school too…<\/p>\n\n\n\n

A quick glance at Faron’s update on \n6th Feb gives a potential reason for their current flamboyant share price, the \nword “coronavirus” popping up in the 3rd paragraph, attracting interest like \npoliticians round a photo opportunity.<\/p>\n\n\n\n

From the point at which the share \nclosed (320p), we can calculate 396p as possible on the current cycle with \nsecondary, if exceeded, coming in at 416p. Obviously, the proximity of these \nnumbers tends suggest the potential of some stutters making themselves known. \nLonger term, we can even calculate 559p as possible but, to be fair, we’re on a \nbit of a wing and a prayer with such a price level.<\/p>\n\n\n\n

Presently, the price needs break Red \non the chart to spoil enthusiasm, this innocent line presently at 222p. Moves \nbelow risk a challenge of 180p with secondary, if broken, down at 51p.<\/p>\n\n\n\n

We mentioned recently the dangers of \nwild price swings, making stop loss levels almost impossible on flamboyant \nshares. We need to mention, politely, the unpleasant reality of Faron as the \nshare price is currently trending in a zone with “bottom” at 220p. It will not \napproach long term safety until the price manages exceed Blue on the chart.<\/p>\n\n\n\n

\"Hey,<\/figure>\n\n\n\n<\/p>\n\n\n
\n\t

Time Issued<\/font><\/td>

\n\t

Market<\/font><\/td>

\n\t

Price At Issue<\/font><\/td>

\n\t

Short Entry<\/font><\/td>

\n\t

Fast Exit<\/font><\/td>

\n\t

Slow Exit<\/font><\/td>

\n\t

Stop<\/font><\/td>

\n\t

Long Entry<\/font><\/td>

\n\t

Fast Exit<\/font><\/td>

\n\t

Slow Exit<\/font><\/td>

\n\t

Stop<\/font><\/td>

\n\t

Prior<\/font><\/td> <\/TR>\nFUTURES<\/font><\/a>

\n\t

10:27:59PM<\/font><\/td>

\n\t

BRENT<\/font><\/td>

\n\t

55.74<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:36:21PM<\/font><\/td>

\n\t

GOLD<\/font><\/td>

\n\t

1660.22<\/font><\/td>

\n\t

1651<\/font><\/td>

\n\t

1642<\/font><\/td>

\n\t

1626<\/font><\/td>

\n\t

1672<\/font><\/td>

\n\t

1690<\/font><\/td>

\n\t

1703.75<\/font><\/td>

\n\t

1720<\/font><\/td>

\n\t

1672<\/font><\/td>

\n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:39:37PM<\/font><\/td>

\n\t

FTSE<\/font><\/td>

\n\t

7129<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:42:18PM<\/font><\/td>

\n\t

FRANCE<\/font><\/td>

\n\t

5754.2<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Shambles<\/font><\/td> <\/TR>\n

\n\t

10:52:42PM<\/font><\/td>

\n\t

GERMANY<\/font><\/td>

\n\t

12993<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:57:18PM<\/font><\/td>

\n\t

US500<\/font><\/td>

\n\t

3228.42<\/font><\/td>

\n\t

3210<\/font><\/td>

\n\t

3183<\/font><\/td>

\n\t

3173<\/font><\/td>

\n\t

3254<\/font><\/td>

\n\t

3266<\/font><\/td>

\n\t

3283.5<\/font><\/td>

\n\t

3307<\/font><\/td>

\n\t

3224<\/font><\/td>

\n\t

Shambles<\/font><\/td> <\/TR>\n

\n\t

11:01:21PM<\/font><\/td>

\n\t

DOW<\/font><\/td>

\n\t

27975<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

11:05:39PM<\/font><\/td>

\n\t

NASDAQ<\/font><\/td>

\n\t

9079.24<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Shambles<\/font><\/td> <\/TR>\n

\n\t

11:09:27PM<\/font><\/td>

\n\t

JAPAN<\/font><\/td>

\n\t

22287<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

‘cess<\/font><\/td> <\/TR>\n\n<\/TABLE>\n\n

 <\/p>\n

24\/02\/2020 FTSE Closed at 7156 points. Change of -3.34%. Total value traded through LSE was: \u00a3 7,457,826,437 a change of 17.05%<\/h><\/p>\n
21\/02\/2020 FTSE Closed at 7403 points. Change of -0.44%. Total value traded through LSE was: \u00a3 6,371,450,688 a change of 1.87%<\/h><\/p>\n
20\/02\/2020 FTSE Closed at 7436 points. Change of -0.28%. Total value traded through LSE was: \u00a3 6,254,655,479 a change of 11.64%<\/h><\/p>\n
19\/02\/2020 FTSE Closed at 7457 points. Change of 1.29%. Total value traded through LSE was: \u00a3 5,602,530,865 a change of -6.87%<\/h><\/p>\n
18\/02\/2020 FTSE Closed at 7362 points. Change of -0.96%. Total value traded through LSE was: \u00a3 6,015,855,072 a change of 44.99%<\/h><\/p>\n
17\/02\/2020 FTSE Closed at 7433 points. Change of 0.32%. Total value traded through LSE was: \u00a3 4,149,027,770 a change of -24.37%<\/h><\/p>\n
14\/02\/2020 FTSE Closed at 7409 points. Change of -0.58%. Total value traded through LSE was: \u00a3 5,485,879,910 a change of -17.68%<\/h><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"

#Gold #SP500 As we snuffle through the cold & flu season, it was interesting to note those shares which proved resilient, despite market wide hysteria apparently prompted by Coronavirus. We covered #Faron last November (link) and their share price has managed the opposite of catching a cold. Equally fascinating, reading “the common cold” is just … <\/p>\n

Continue reading “Faron Pharma (LSE:FARN) 25\/02\/2020”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1608","post","type-post","status-publish","format-standard","hentry","category-trendsandtargets"],"_links":{"self":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/comments?post=1608"}],"version-history":[{"count":2,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1608\/revisions"}],"predecessor-version":[{"id":1611,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1608\/revisions\/1611"}],"wp:attachment":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/media?parent=1608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/categories?post=1608"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/tags?post=1608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}